BAT’s US Bio-tech arm, Kentucky BioProcessing (KBP) today announced plans to commence a Phase I first-time-in-human study of its COVID-19 vaccine candidate following approval of its Investigational New Drug application by the U.S. Food and Drug Administration (FDA). Enrollment for the study is expected to begin shortly. Full press release, intended for use by the media only, available at BAT.com.
Latest Articles
Reynolds American Unveils 50,000 Square Foot Mural on Reynolds Boulevard
The new public art piece by artists Leo Rucker and Joey Allen creates a lasting public tribute to the shared history of Reynolds American and Winston-Salem Winston-Salem, N.C. (Sept. 9, 2026) – The Reynolds American organization (Reynolds American) celebrated the new Reynolds Boulevard Mural in Winston-Salem, North Carolina at a viewing yesterday evening. The event brought … Continued
Reynolds American Submits Comment on FDA Draft Guidance for Flavored ENDS
In response to FDA’s open public comment period in March of 2026 regarding Draft Guidance on Applications for Flavored E-Cigarettes, Reynolds American submitted the following comment: Re: Docket No. FDA-2026-D-1817 (91 Fed. Reg. 11980, Mar. 11, 2026) – “Flavored Electronic Nicotine Delivery Systems (ENDS) Premarket Applications—Considerations Related to Youth Risk” RAI Services Company … Continued
Reynolds American Expands Manufacturing Workforce at American Snuff Company in Clarksville
More than 50 new manufacturing roles at Clarksville facility underscores continued investment in future-ready U.S. manufacturing careers. Clarksville, Tenn., (March 26, 2026) – As part of the Reynolds American companies’ (Reynolds American) significant investment in American manufacturing, American Snuff Company, a Reynolds American company, is hiring more than 50 new manufacturing roles at its Clarksville, … Continued
Growing Tomorrow: Reynolds American Commits to Invest $3.2 Billion by 2030 to Grow U.S. Manufacturing and Innovation
Investment supports more than 2,000 U.S. jobs while expanding manufacturing capacity and fueling innovation across a multicategory portfolio WINSTON-SALEM, N.C., (March 5, 2026) — The Reynolds American companies (Reynolds American) announced a forward-looking commitment to invest more than $3.2 billion across its U.S. operations by 2030, reinforcing its long-term focus on value creation and … Continued